Dear Colleagues:
Please join EULAR in learning about highlights of some of the best presentations from the 2022 Congress, focusing on the clinical and therapeutic findings that will change the way rheumatologists and health professionals practise medicine.
Highlights include:
EULAR recommends starting methotrexate and glucocorticoids in RA management
Stopping immunosuppressives in lupus nephritis proved worse than continuing them
Immunosuppressed patients with rheumatic diseases not at high risk of breakthrough COVID
With very best regards,
Annamaria Iagnocco
EULAR President
